GAZI MEDICAL JOURNAL, cilt.33, sa.1, ss.53-57, 2022 (ESCI)
Background: Down Syndrome (DS) can be diagnosed with prenatal invasive diagnostic tests to the risky population. In this study, it was aimed to propound the status of the oxidant/antioxidant system and interleukin-6 (IL-6)/interleukin-10 (IL-10) levels in the amniotic fluids of pregnant women with DS diagnosed child by amniocentesis method.